Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s Special Access Program Post published:September 27, 2023 Post category:Press Release
Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer Post published:August 10, 2023 Post category:Press Release
Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada USA – English USA – English Post published:June 9, 2023 Post category:Press Release
Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical Trial by Health Canada Post published:April 20, 2023 Post category:Press Release
Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial Post published:March 29, 2023 Post category:Press Release
Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical Trial Post published:February 1, 2023 Post category:Press Release
Apex Labs Granted Approval for North America’s First Take Home Psilocybin Clinical Trial Post published:November 1, 2022 Post category:Press Release